Diagnostic usefulness of the growth hormone-releasing peptide-2 test as a substitute for the insulin tolerance test in hypopituitarism

Endocrine Journal

Volumn 55, Issue 4, 2008, Pages 777-783

  Kageyama, Kazunori ^a   Nigawara, Takeshi ^a   Sakihara, Satoru ^a   Takayasu, Shinobu ^a   Terui, Ken ^a   Moriyama, Takako ^a   Suda, Toshihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

ACTH; Growth hormone; Hypothalamus; Pituitary; Stress

Indexed keywords

CORTICOTROPIN; PRALMORELIN;

ADOLESCENT; ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPHYSIS DISEASE; HYPOPITUITARISM; HYPOTHALAMUS DISEASE; INSULIN TOLERANCE TEST; MALE;

ADOLESCENT; ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN; MALE; MIDDLE AGED; OLIGOPEPTIDES; PITUITARY-ADRENAL SYSTEM;

EID: 51449111885     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K07E-168     Document Type: Article

References (23)

1. Wilson TA, Blizzard RM (1994) Adrenal insufficiency in childhood. In: Lavin N (ed) Manual of endocrinology and metabolism, 2nd ed. Little, Brown and Company, Boston: 181-186.
2. Sakihara S, Kageyama K, Nigawara T, Kidani Y, Suda T (2007) Ampulla (takotsubo) cardiomyopathy caused by secondary adrenal insufficiency in ACTH isolated deficiency. Endocr J 54: 631-636.
3. Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41 residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213: 1394-1397.
4. Whitnall MH (1993) Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol 40: 573-629.
5. Suda T, Tozawa F, Yamada M, Ushiyama T, Tomori N, Sumitomo T, Nakagami Y, Demura H, Shizume K (1988) Insulin-induced hypoglycemia increases corticotropin-releasing factor messenger ribonucleic acid levels in rat hypothalamus. Endocrinology 123: 1371-1375.
6. Jones SL, Trainer PJ, Perry L, Wass JA, Bessser GM, Grossman A (1994) An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol (Oxf) 41: 123-128.
7. Chihara K, Shimatsu A, Hizuka N, Tanaka T, Seino Y, Katofor Y; KP-102 Study Group (2007) A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency. Eur J Endocrinol 157: 19-27.
8. Bowers CY (1993) GH releasing peptides - structure and kinetics. J Pediatr Endocrinol 6: 21-31.
9. Doi N, Hirotani C, Ukai K, Shimada O, Okuno T, Kurasaki S, Kiyofuji T, Ikegami R, Futamata M, Nakagawa T, Ase K, Chihara K (2004) Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. Arzneimittelforschung 54: 857-867.
10. Mozid AM, Tringali G, Forsling ML, Hendricks MS, Ajodha S, Edwards R, Navarra P, Grossman AB, Korbonits M (2003) Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin. Horm Metab Res 35: 455-459.
11. Korbonits M, Kaltsas G, Perry LA, Putignano P, Grossman AB, Besser GM, Trainer PJ (1999) The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. J Clin Endocrinol Metab 84: 2489-2495.
12. Gondo RG, Aguiar-Oliveira MH, Hayashida CY, Toledo SP, Abelin N, Levine MA, Bowers CY, Souza AH, Pereira RM, Santos NL, Salvatori R (2001) Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficient patients with mutated GH-releasing hormone receptor. J Clin Endocrinol Metab 86: 3279-3283.
13. Arvat E, di Vito L, Maccagno B, Broglio F, Boghen MF, Deghenghi R, Camanni F, Ghigo E (1997) Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. Peptides 18: 885-891.
14. Hirotani C, Oki Y, Ukai K, Okuno T, Kurasaki S, Ohyama T, Doi N, Sasaki K, Ase K (2005) ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF. Naunyn Schmiedebergs Arch Pharmacol 371: 54-60.
15. Kageyama K, Hanada K, Iwasaki Y, Sakihara S, Nigawara T, Kasckow J, Suda T (2007) Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells. J Endocrinol 195: 199-211.
16. Swanson LW, Sawchenko PE, Lind RW, Rho JH (1987) The CRH motoneuron: differential peptide regulation in neurons with possible synaptic, paracrine, and endocrine outputs. Ann N Y Acad Sci 512: 12-23.
17. Gonzalez-Hernandez T, Afonso-Oramas D, Cruz-Muros I, Barroso-Chinea P, Abreu P, del Mar Perez-Delgado M, Rancel-Torres N, del Carmen Gonzalez M (2006) Interleukin-6 and nitric oxide synthase expression in the vasopressin and corticotrophin-releasing factor systems of the rat hypothalamus. J Histochem Cytochem 54: 427-441.
18. Gillies GE, Linton EA, Lowry PJ (1982) Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299: 355-357.
19. Mouri T, Itoi K, Takahashi K, Suda T, Murakami O, Yoshinaga K, Andoh N, Ohtani H, Masuda T, Sasano N (1993) Colocalization of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of the human hypothalamus. Neuroendocrinology 57: 34-39.
20. Arvat E, Ceda GP, Di Vito L, Ramunni J, Gianotti L, Broglio F, Deghenghi R, Ghigo E (1998) Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging. Pituitary 1: 51-58.
21. Arvat E, Maccagno B, Ramunni J, Di Vito L, Gianotti L, Broglio F, Benso A, Deghenghi R, Camanni F, Ghigo E (1998) Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans. Neuroendocrinology 67: 310-316.
22. Edwards CA, Dieguez C, Scanlon MF (1989) Effects of hypothyroidism, tri-iodothyronine and glucocorticoids on growth hormone responses to growth hormone-releasing hormone and His-D-Trp-Ala-Trp-D-Phe-Lys-NH2. J Endocrinol 121: 31-36.
23. Oliveira JH, Vieira JG, Abucham J, Lengyel AM (2003) GHRP-6 is able to stimulate cortisol and ACTH release in patients with Cushing's disease: comparison with DDAVP. J Endocrinol Invest 26: 230-235.